EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent

N Mottet, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians

WA Hall, E Paulson, XA Li, B Erickson… - CA: a cancer journal …, 2022 - Wiley Online Library
Radiation therapy (RT) continues to play an important role in the treatment of cancer.
Adaptive RT (ART) is a novel method through which RT treatments are evolving. With the …

Magnetic resonance imaging–guided vs computed tomography–guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial

AU Kishan, TM Ma, JM Lamb, M Casado… - JAMA …, 2023 - jamanetwork.com
Importance Magnetic resonance imaging (MRI) guidance offers multiple theoretical
advantages in the context of stereotactic body radiotherapy (SBRT) for prostate cancer …

[HTML][HTML] Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

A Esteva, J Feng, D van der Wal, SC Huang… - NPJ digital …, 2022 - nature.com
Prostate cancer is the most frequent cancer in men and a leading cause of cancer death.
Determining a patient's optimal therapy is a challenge, where oncologists must select a …

[HTML][HTML] Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

C Parker, E Castro, K Fizazi, A Heidenreich… - Annals of …, 2020 - annalsofoncology.org
Subclinical prostate cancer is common in men> 50 years. Population-based screening of
men aged between 55 and 69 years, using prostate-specific antigen (PSA) testing, has been …

Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer

AU Kishan, A Dang, AJ Katz, CA Mantz… - JAMA network …, 2019 - jamanetwork.com
Importance Stereotactic body radiotherapy harnesses improvements in technology to allow
the completion of a course of external beam radiotherapy treatment for prostate cancer in the …

Comparative effectiveness of proton vs photon therapy as part of concurrent chemoradiotherapy for locally advanced cancer

BC Baumann, N Mitra, JG Harton, Y Xiao… - JAMA …, 2020 - jamanetwork.com
Importance Concurrent chemoradiotherapy is the standard-of-care curative treatment for
many cancers but is associated with substantial morbidity. Concurrent chemoradiotherapy …

Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis

LA Gharzai, R Jiang, D Wallington, G Jones… - The Lancet …, 2021 - thelancet.com
Summary Background The international Intermediate Clinical Endpoints in Cancer of the
Prostate working group has established metastasis-free survival as a surrogate for overall …

[HTML][HTML] Local failure events in prostate cancer treated with radiotherapy: a pooled analysis of 18 randomized trials from the meta-analysis of randomized trials in …

TM Ma, FI Chu, H Sandler, FY Feng, JA Efstathiou… - European urology, 2022 - Elsevier
Context The prognostic importance of local failure after definitive radiotherapy (RT) in
National Comprehensive Cancer Network intermediate-and high-risk prostate cancer (PCa) …

Artificial intelligence predictive model for hormone therapy use in prostate cancer

DE Spratt, S Tang, Y Sun, HC Huang, E Chen… - NEJM …, 2023 - evidence.nejm.org
Background Androgen deprivation therapy (ADT) with radiotherapy can benefit patients with
localized prostate cancer. However, ADT can negatively impact quality of life, and there …